In patients with chronic valvular or myocardial disease, chronic increases in resting ventricular metabolic requirements appear to be met by myocardial hypertrophy rather than by increased myocardial oxygen consumption per unit of mass.
No takes yet. Share an insight, caveat, or question.
LV efficiency varies widely in valvular disease; supports hypertrophy as compensation but leaves open prospective validation.
Baxley et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: